Heron Therapeutics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
1,279.00
30,767.00
77,474
Cost of Goods Sold (COGS) incl. D&A
333.00
578.00
734.00
1,134.00
4,588.00
27,512
Gross Income
333.00
578.00
734.00
145.00
26,179.00
49,962
SG&A Expense
54,124.00
73,983.00
96,191.00
163,260.00
218,937.00
233,899
EBIT
54,457.00
74,561.00
96,925.00
163,115.00
192,758.00
183,937
Unusual Expense
-
-
-
7,800.00
1,800.00
-
Non Operating Income/Expense
-
919.00
292.00
436.00
38.00
1,804
Interest Expense
826.00
887.00
958.00
2,664.00
3,937.00
2,672
Pretax Income
55,283.00
76,367.00
97,591.00
173,143.00
197,484.00
178,840
Consolidated Net Income
55,283.00
76,367.00
97,591.00
173,143.00
197,484.00
178,840
Net Income
55,283.00
76,367.00
97,591.00
173,143.00
197,484.00
178,840
Net Income After Extraordinaries
55,283.00
76,367.00
97,591.00
173,143.00
197,484.00
178,840
Net Income Available to Common
55,283.00
76,367.00
97,591.00
173,143.00
197,484.00
178,840
EPS (Basic)
3.42
2.87
2.95
4.57
3.65
2.44
Basic Shares Outstanding
16,163.00
26,569.00
33,081.00
37,925.00
54,040.00
73,193
EPS (Diluted)
3.42
2.87
2.95
4.57
3.65
2.44
Diluted Shares Outstanding
16,163.00
26,569.00
33,081.00
37,925.00
54,040.00
73,193
EBITDA
54,124.00
73,983.00
96,191.00
162,016.00
191,227.00
182,424
Non-Operating Interest Income
-
-
-
-
1,049.00
5,965
About Heron Therapeutics
View Profile
